- Home
- KTTA vs GROW Comparison
KTTA vs GROW Comparison
Compare KTTA & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KTTA | GROW |
|---|---|---|
| Founded | 2020 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 31.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | KTTA | GROW |
|---|---|---|
| Price | $0.85 | $3.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 250.2K | 76.0K |
| Earning Date | 11-13-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 3.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $8,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $44.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $2.02 |
| 52 Week High | $3.85 | $2.96 |
Technical Indicators
Market Signals| Indicator | KTTA | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 85.78 |
| Support Level | $0.86 | $2.58 |
| Resistance Level | $0.92 | $2.61 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 9.71 | 97.99 |
Price Performance
Historical ComparisonAbout KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.